2- (2- (3,5- difluorophenyl)- 2- hydroxyacetamido)- N- (3- methyl- 4- oxo- 4,5- dihydro- 3H- benzo(d)(1,2)diazepin- 5- yl)propanamide
has amyloid beta lowering activity; structure in first source
Also Known As:
BMS 433796; BMS-433796; BMS433796
Networked: 1
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Barten, Donna M:
1 article
(07/2007)
|
2. | Bergstrom, Carl:
1 article
(07/2007)
|
3. | Corsa, Jason A:
1 article
(07/2007)
|
4. | Dangler, Charles:
1 article
(07/2007)
|
5. | Gao, Qi:
1 article
(07/2007)
|
6. | Guss, Valerie L:
1 article
(07/2007)
|
7. | Hendrick, Joseph P:
1 article
(07/2007)
|
8. | Loo, Alice:
1 article
(07/2007)
|
9. | Polson, Craig T:
1 article
(07/2007)
|
10. | Prasad, C V C:
1 article
(07/2007)
|
Related Diseases
Related Drugs and Biologics